FDA NDC Directory · JSON-LD · Markdown

Cabergoline

NDC 0093-5420 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerTeva Pharmaceuticals USA, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA077750
Dosage form / routeTABLET · ORAL
Active ingredientsCABERGOLINE (.5 mg/1)
Marketing started20070307
Package count1

External sources

Source: openFDA. Public-domain (CC0).